Home Your basket
• Subcutaneous emphysema an...
   Price 5.50 €
• Retropharyngeal abscess i...
   Price 10.50 €
• Cholesteatoma by osteoma ...
   Price 8.50 €
• Psychosocial quality of l...
   Price 10.50 €
• Stuttering of the “Miror”...
   Price 5.50 €
• Reconstruction after tumo...
   Price 10.50 €
• Partial allotransplantati...
   Price 10.50 €
• Schwannoma of the tongue:...
   Price 5.50 €
• Otologic surgery in HIV-i...
   Price 8.50 €
• Adenocarcinoma of the end...
   Price 8.50 €
• Sinonasal hemangiopericyt...
   Price 8.50 €
• Functional results of vel...
   Price 5.50 €
• A single appointment with...
   Price 8.50 €
• Cochlear implantation in ...
   Price 10.50 €
• Evaluation of a dysphonic...
   Price 10.50 €
• Surgical treatement by in...
   Price 12.50 €
• Transsexualism: From diag...
   Price 10.50 €
• Nasal septal abscess: A c...
   Price 5.50 €
• The clinical significance...
   Price 5.50 €
• Abscess tonsillectomy for...
   Price 10.50 €
• Usefulness and limitation...
   Price 10.50 €
• Epitympanic osteoma of th...
   Price 12.50 €
• Understanding the use of ...
   Price 10.50 €
• Rhinoplasty: Morphodynami...
   Price 10.50 €
• XVIth World Congress of O...
   Price 8.50 €
• Sarcoidosis of the thyroi...
   Price 12.50 €
• Teeth and sinuses...
   Price 8.50 €
• Total pharyngolayngectomy...
   Price 10.50 €
• Cataract surgery and its ...
   Price 10.50 €
• Induction chemotherapy an...
   Price 10.50 €
• Vocal forcing and posture...
   Price 10.50 €
• The use of ultrasound eva...
   Price 8.50 €

Total Order 296.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2016 o

RHINOLOGY

Efficacy of nasal irrigation with 2.2% hypertonic seawater in the treatment of chronic rhinosinusitis in adults


Authors : Strnad P, Skoupá J, HornÍk P, Cimrová H, Cerná V. (Prague)

Ref. : Rev Laryngol Otol Rhinol. 2016;137,1:3-10.

Article published in english
Downloadable PDF document english



Summary : Objective: To evaluate the efficacy and the tolerance of nasal irrigation with 2.2% hypertonic seawater in the treatment of chronic rhinosinusitis (CRS) in adults either used as mono­therapy, or in combination with intranasal corticosteroids. Method: In this prospective, open-label, multicenter controlled trial, 238 patients diagnosed with CRS were randomly assigned to three groups: group 1 with intranasal corticosteroids (steroid), group 2 with nasal irrigation with hypertonic seawater (seawater) and group 3 with a treatment combining intranasal corticosteroids at lower dose and seawater (steroid+seawater). Nasal index score (NIS), patient health status, intranasal corticosteroids intake, tolerance were assessed at baseline, week 2 and 6, and satisfaction at week 6. Results: NIS was significantly improved in group 2 (seawater) and group 3 (steroid+seawater) at week 2 (p< 0.001 in both groups) and week 6 (p< 0.0001 in both groups) compared to group 1 (steroid), along with a significant decrease of intranasal corticosteroids (p < 0.0001). Patient health status improved in group 2 and group 3 at week 2 (p= 0.1040 and p< 0.001 respectively) compa­red to control (steroid), and this improvement was significantly greater in both groups at week 6 compared to steroid group (p< 0.0001). Conclusion: Hypertonic nasal irrigation is an effective treatment for CRS in adults. It significantly improved nasal symptoms and allowed a signi­fi­cant decrease of intranasal corticosteroids use while improving patient health status. Nasal irrigation with 2.2% hypertonic seawater could therefore be considered as first-line treatment for CRS, either as monotherapy or in combination with lower dosage of intranasal corticosteroids.

Price : 15.00 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE